In vivo models that are highly predictive to human pharmacodynamics.

Vivexia’s in vivo expertise in the pharmacology of anti-infective drugs allows us to assess the pre clinical efficacy of the incoming treatments.

Our models (mouse, rat, rabbit) cover the numerous stages of pre clinical development (from screening to the precise determination of the pharmacodynamics parameters associated with efficacy or failure).

They are perfectly suited to the evaluation of a wide range of anti-infective drugs (peptides, small biological molecules, vaccines, natural products, bacteriophages, etc.).